NO761087L - - Google Patents
Info
- Publication number
- NO761087L NO761087L NO761087A NO761087A NO761087L NO 761087 L NO761087 L NO 761087L NO 761087 A NO761087 A NO 761087A NO 761087 A NO761087 A NO 761087A NO 761087 L NO761087 L NO 761087L
- Authority
- NO
- Norway
- Prior art keywords
- water
- regulating agent
- soluble
- agent
- bowel
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 20
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 18
- 229910052782 aluminium Inorganic materials 0.000 claims description 15
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 15
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 15
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 14
- 230000001105 regulatory effect Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 239000011358 absorbing material Substances 0.000 claims description 9
- 229920000615 alginic acid Polymers 0.000 claims description 9
- 206010010774 Constipation Diseases 0.000 claims description 8
- 235000010443 alginic acid Nutrition 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 239000001814 pectin Substances 0.000 claims description 8
- 235000010987 pectin Nutrition 0.000 claims description 8
- 229920001277 pectin Polymers 0.000 claims description 8
- 229960000292 pectin Drugs 0.000 claims description 8
- 239000000230 xanthan gum Substances 0.000 claims description 8
- 229920001285 xanthan gum Polymers 0.000 claims description 8
- 235000010493 xanthan gum Nutrition 0.000 claims description 8
- 229940082509 xanthan gum Drugs 0.000 claims description 8
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 claims description 7
- 239000000783 alginic acid Substances 0.000 claims description 7
- 229960001126 alginic acid Drugs 0.000 claims description 7
- 150000004781 alginic acids Chemical class 0.000 claims description 7
- 230000000968 intestinal effect Effects 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 239000004067 bulking agent Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000002522 swelling effect Effects 0.000 claims description 4
- 208000019399 Colonic disease Diseases 0.000 claims description 3
- 230000002572 peristaltic effect Effects 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 239000007900 aqueous suspension Substances 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims 1
- 230000002745 absorbent Effects 0.000 claims 1
- 239000002250 absorbent Substances 0.000 claims 1
- 239000006096 absorbing agent Substances 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 230000008961 swelling Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 239000002244 precipitate Substances 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 10
- 239000008141 laxative Substances 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 229940125722 laxative agent Drugs 0.000 description 5
- 230000002475 laxative effect Effects 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical group OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 229920000896 Ethulose Polymers 0.000 description 1
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940040387 citrus pectin Drugs 0.000 description 1
- 239000009194 citrus pectin Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000007911 effervescent powder Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002468 fat body Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- -1 iron (III) ions Chemical class 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7504053A SE7504053L (sv) | 1975-04-09 | 1975-04-09 | Svellmedel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO761087L true NO761087L (OSRAM) | 1976-10-12 |
Family
ID=20324217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO761087A NO761087L (OSRAM) | 1975-04-09 | 1976-03-29 |
Country Status (12)
| Country | Link |
|---|---|
| JP (1) | JPS51142546A (OSRAM) |
| AU (1) | AU1275176A (OSRAM) |
| BE (1) | BE840555A (OSRAM) |
| DE (1) | DE2614455A1 (OSRAM) |
| DK (1) | DK153276A (OSRAM) |
| FI (1) | FI760960A7 (OSRAM) |
| FR (1) | FR2306706A1 (OSRAM) |
| LU (1) | LU74731A1 (OSRAM) |
| NL (1) | NL7603360A (OSRAM) |
| NO (1) | NO761087L (OSRAM) |
| NZ (1) | NZ180551A (OSRAM) |
| SE (1) | SE7504053L (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3332301A1 (de) * | 1983-09-07 | 1985-03-21 | Algina AG, Zug | Metallsalze und metallmischsalze von polymeren, anionischen carbonsaeuren und/oder ihren schwefelsaeureestern, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und ihre verwendung |
| JPS63165325A (ja) * | 1986-12-27 | 1988-07-08 | Snow Brand Milk Prod Co Ltd | 整腸剤 |
| DK179687D0 (da) * | 1987-04-08 | 1987-04-08 | Farma Food As | Praeparat |
| CA2523339A1 (en) * | 2003-04-25 | 2004-11-11 | Kouki Bussan Yugenkaisha | Agent for preventing and healing constipation |
-
1975
- 1975-04-09 SE SE7504053A patent/SE7504053L/xx unknown
-
1976
- 1976-03-29 NO NO761087A patent/NO761087L/no unknown
- 1976-03-31 DK DK153276A patent/DK153276A/da not_active IP Right Cessation
- 1976-03-31 NL NL7603360A patent/NL7603360A/xx not_active Application Discontinuation
- 1976-04-03 DE DE19762614455 patent/DE2614455A1/de active Pending
- 1976-04-07 AU AU12751/76A patent/AU1275176A/en not_active Expired
- 1976-04-08 FI FI760960A patent/FI760960A7/fi not_active Application Discontinuation
- 1976-04-08 FR FR7610341A patent/FR2306706A1/fr active Granted
- 1976-04-08 NZ NZ180551A patent/NZ180551A/xx unknown
- 1976-04-09 LU LU74731A patent/LU74731A1/xx unknown
- 1976-04-09 BE BE165984A patent/BE840555A/xx unknown
- 1976-04-09 JP JP51040202A patent/JPS51142546A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2614455A1 (de) | 1976-10-28 |
| JPS51142546A (en) | 1976-12-08 |
| DK153276A (da) | 1976-10-10 |
| SE7504053L (sv) | 1976-10-10 |
| FI760960A7 (OSRAM) | 1976-10-10 |
| BE840555A (fr) | 1976-10-11 |
| NZ180551A (en) | 1978-04-28 |
| AU1275176A (en) | 1977-10-20 |
| FR2306706A1 (fr) | 1976-11-05 |
| LU74731A1 (OSRAM) | 1977-02-04 |
| FR2306706B1 (OSRAM) | 1979-03-16 |
| NL7603360A (nl) | 1976-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saghir et al. | Structure characterization and carboxymethylation of arabinoxylan isolated from Ispaghula (Plantago ovata) seed husk | |
| JPH0745521B2 (ja) | 高血圧降下作用を有する高血圧降下剤 | |
| JP2002138035A (ja) | カプセルの密封方法 | |
| KR100255887B1 (ko) | 유산균 함유 설사약 조성물 | |
| EP0236124A2 (en) | Beta-d-glucan, and its production and uses | |
| WO2020113812A1 (zh) | 含nadh的生物高分子纳米球及其制备方法与应用 | |
| CN113521305A (zh) | 一种蜂胶醇提物-环糊精-壳聚糖-黏蛋白缓释凝胶及其制备方法和应用 | |
| JP4321007B2 (ja) | 多糖類複合体及びその製造方法 | |
| WO1997006808A1 (en) | Combination osmotic and bulk forming laxatives | |
| CN113841904A (zh) | 一种魔芋凝胶粉的制备方法及应用 | |
| JPS61205213A (ja) | 製剤組成物 | |
| CN104324016A (zh) | 一种软胶囊囊材配方 | |
| BRPI0821454B1 (pt) | formulação farmacêutica, mistura de glicogênio, alginato e sais de metais alcalino terrosos, processos para a produção de um excipiente de liberação lenta, e de uma forma farmacêutica | |
| NO159697B (no) | Fremgangsmaate ved fremstilling av nye komplekser av carrageenan og emepron, doxycyclin eller propranolol. | |
| NO761087L (OSRAM) | ||
| US4225614A (en) | Method of treatment for mucocutaneous herpes simplex infections | |
| KR100705372B1 (ko) | 시클레소나이드 함유 수성 약학 조성물 | |
| CN106188324A (zh) | 羟乙基茯苓多糖的制备及其作为缓释片骨架材料的应用 | |
| JPH07508532A (ja) | 活性物質の制御された放出のための組成物ならびにそのような組成物の調製方法 | |
| KR100644149B1 (ko) | 사하제 | |
| US20200046762A1 (en) | Smectite suspension liquid composition and method for preparing same | |
| Madhulika et al. | A review on natural and synthetic polymers employed in the formulation of oral disintegrating tablets | |
| JPS63185352A (ja) | 腫瘍の予防効果を有する食品 | |
| Dev et al. | Preparation and evaluation of modified tamarind seed gum as a novel superdisintegrant | |
| JP3231276B2 (ja) | キトサン組成物およびその製造方法 |